Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03308877 · ClinicalTrials.gov registry record · NA
Brief Intervention for Justice-Involved Substance Users
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT03308877: Completed NA study, sponsored by University of Rochester.
NCT03308877 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03308877, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
This is a randomized clinical trial to study ways of helping justice-involved people change to more healthy behavior.
Primary Outcome
Percent Days not using alcohol or drugs
Interventions
- BEHAVIORAL BMI
- BEHAVIORAL Stadard Care (SC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2023-08-01 |
| Phase | NA |
What the finished NCT03308877 record still lists
NCT03308877 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which BMI is the first listed.
NCT03308877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03308877 about?
NCT03308877 is a clinical study titled "Brief Intervention for Justice-Involved Substance Users". This is a randomized clinical trial to study ways of helping justice-involved people change to more healthy behavior.
What is the current status of trial NCT03308877?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2018-02-01. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT03308877?
The interventions under investigation include: BMI (BEHAVIORAL), Stadard Care (SC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03308877?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03308877's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI